Workshop organised by the RIA Committee for Life Sciences

registration fee: €20, concession rate €10 - click here to register online

This one day workshop which is being organised by the Academy Committee for Life Sciences is aimed at highlighting:

• Current challenges with lung disease treatments,
• Clinical and scientific progress with new treatment strategies,
• Enterprise opportunities between clinicians, scientists, industry and agencies on the island of Ireland with an interest in translational research in the area of respiratory disease, with a focus on medical devices, therapeutics and diagnostics.

A series of presentations by clinicians, researchers and companies will be followed by a session to discuss the establishment of a network of interested parties. The network will aim to identify research capacities, needs and opportunities with a view to developing a strategic response to the challenges in lung disease treatment. The network will use the NUIM/DCU/RCSI Translational Research Hub (TRH) as a framework but will be all-inclusive.

Abstracts are also invited for consideration for inclusion as scientific/clinical poster presentations and there will be a prize for the best poster. To download a copy of the abstract submission form please click here. Completed forms must be returned Shirley.odea@nuim.ie by no later than 21 August 2012

Programme

9.00am Registration
9.20am Welcome and Introduction by Dr Shirley O’Dea (NUI Maynooth & Academy Committee for Life Sciences)

Session One: Challenges in Lung Diseases Treatment

Chair: Professor Brian Harvey (RCSI & Academy Committee for Life Sciences)
9.30am Dr Judy Bradley (University of Ulster): Northern Ireland Clinical Research Network - Respiratory Health
9.50am Ms Sharon Higgins (IBEC – Irish Medical Devices Association): Ireland – overview/general clinical challenge
10.10am Professor Jim Egan (Mater Misericordiae University Hospital, Dublin): COPD
10.30am Professor Richard Costello (RCSI Beaumont Hospital): Asthma
10.50am Dr Barry Plant (Cork University Hospital): Cystic Fibrosis
11.10am Coffee and Poster Session

Session Two: New Strategies to Treat Lung Diseases (I)

Chair: Professor Jim Egan (Mater Misericordiae University Hospital, Dublin)
11.20am Professor Gerry McElvaney (RCSI Beaumont Hospital): Alpha-1 Antitrypsin: A Potent Anti-Inflammatory and Potential Novel Therapeutic Agent
11.40am Dr Valerie Urbach (National Children’s Research Centre, OLCH Crumlin Hospital): Novel Therapeutic Actions of Lipoxin in CF Airway Disease.
12.00pm Dr Warren Thomas (RCSI Beaumont Hospital): Novel Therapeutic Targets and Predictive Markers in Pleural Mesothelioma
12.20pm Lunch and Poster Session

Session Three: New Strategies to Treat Lung Diseases (II)

Chair: Professor Stephanie McKeown (University of Ulster & Academy Committee for Life Sciences)
1.40pm Dr Shirley O’Dea (NUI Maynooth & Academy Committee for Life Sciences): Electrospray: A Novel Delivery Technology
2.00pm Dr Paul Dowling (Dublin City University): Lung Disease Biomarker Discovery
2.20pm Dr Ronan MacLoughlin (Aerogen): Neublisation
2.40pm Dr Sally-Ann Cryan (RCSI): Nanoparticles
3.00pm Coffee and Poster Session

Session Four: Translation Network Discussion

Chair: Dr Bernard Mahon (NUI Maynooth)
3.30pm Professor Mark Ferguson (SFI): SFI Translational Research Strategy
3.50pm Dr Anne Cody (HRB): Translational Research Strategy
4.10pm Discussion Around Proposal For Network
5.00pm Coffee and Poster Session

Keynote Address

5.30pm Professor Stuart Elborn (Queen’s University Belfast): Cystic Fibrosis

6.00pm Wine Reception